NasdaqCM - Delayed Quote USD
Avenue Therapeutics, Inc. (ATXI)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 7:51 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
10,718.0000
14,540.0000
8,043.0000
3,738.0000
5,213.0000
Operating Income
-10,718.0000
-14,540.0000
-8,043.0000
-3,738.0000
-5,213.0000
Net Non Operating Interest Income Expense
132.0000
-206.0000
-1,140.0000
7.0000
62.0000
Other Income Expense
4,666.0000
4,258.0000
5,580.0000
--
--
Pretax Income
-5,920.0000
-10,488.0000
-3,603.0000
-3,731.0000
-5,151.0000
Net Income Common Stockholders
-14,676.0000
-10,377.0000
-3,552.0000
-3,731.0000
-5,151.0000
Diluted NI Available to Com Stockholders
-14,676.0000
-10,377.0000
-3,552.0000
-3,731.0000
-5,151.0000
Basic EPS
37.48
-73.50
-122.25
-246.75
-348.75
Diluted EPS
37.48
-73.50
-122.25
-246.75
-348.75
Basic Average Shares
516.7200
141.2210
29.1350
15.1080
14.6720
Diluted Average Shares
516.7200
141.2210
29.1350
15.1080
14.6720
Total Operating Income as Reported
-10,718.0000
-14,540.0000
-8,043.0000
-3,738.0000
-5,213.0000
Total Expenses
10,718.0000
14,540.0000
8,043.0000
3,738.0000
5,213.0000
Net Income from Continuing & Discontinued Operation
-14,676.0000
-10,377.0000
-3,552.0000
-3,731.0000
-5,151.0000
Normalized Income
-19,342.0000
-14,635.0000
-9,132.0000
-3,731.0000
-5,151.0000
Interest Income
132.0000
126.0000
20.0000
7.0000
62.0000
Interest Expense
--
332.0000
1,160.0000
--
--
Net Interest Income
132.0000
-206.0000
-1,140.0000
7.0000
62.0000
EBIT
-5,920.0000
-10,156.0000
-2,443.0000
-3,731.0000
-5,213.0000
EBITDA
-5,920.0000
-10,156.0000
-2,443.0000
-3,731.0000
-5,213.0000
Net Income from Continuing Operation Net Minority Interest
-14,676.0000
-10,377.0000
-3,552.0000
-3,731.0000
-5,151.0000
Total Unusual Items Excluding Goodwill
4,666.0000
4,258.0000
5,580.0000
--
--
Total Unusual Items
4,666.0000
4,258.0000
5,580.0000
--
--
Normalized EBITDA
-10,586.0000
-14,414.0000
-8,023.0000
-3,731.0000
-5,213.0000
12/31/2020 - 6/27/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NRBO NeuroBo Pharmaceuticals, Inc.
2.9200
-3.63%
PALI Palisade Bio, Inc.
3.9100
+0.51%
ADIL Adial Pharmaceuticals, Inc.
1.0700
+5.94%
INM InMed Pharmaceuticals Inc.
0.2900
+21.04%
SNPX Synaptogenix, Inc.
3.6000
+11.46%
FBIO Fortress Biotech, Inc.
1.7800
-2.73%
PHIO Phio Pharmaceuticals Corp.
3.1800
+9.28%
ENSC Ensysce Biosciences, Inc.
0.2060
+15.73%
ATHE Alterity Therapeutics Limited
1.2200
-3.17%
XRTX XORTX Therapeutics Inc.
1.7100
-9.04%